Article
Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel.
Platelets - 1 Jan 2015
Sun Wenshan, Li Yongkun, Li Junrong, Zhang Zhizhong, Zhu Wusheng, Liu Wenhua, Cai Qiankun, Wang Xiaomeng, Cao Liping, Bai Wen, Fan Xinying, Ma Minmin, Guo Ruibing, Liu Xinfeng, Xu Gelin
Abstract excerpt
Polymorphisms of CYP2C19 have been associated with variant risk of subsequent cardiovascular events in survivors of myocardial infarction (MI) receiving clopidogrel. This study evaluated the impacts of CYP2C19 polymorphisms on stroke recurrence and other vascular events in a cohort of Chinese patients receiving clopidogrel. From Nanjing Stroke Registry Program, 625 consecutive patients with ischemic stroke were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
